Valentis, Gendaq Announce Gene Regulation Technology Developments | GenomeWeb

NEW YORK, Feb 14 - In two separate signs on Wednesday that gene regulation technology is beginning to gain momentum, Wyeth-Ayerst Laboratories announced it would license Valentis' gene regulation technology, and London-based Gendaq published a scientific explanation of its "zinc finger" gene switches in this week's Proceedings of the National Academy of Sciences.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."